Sanaz Hariri
Orthopedic Surgery · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 6 carriers
- Offices
- 2
Offices
2 locations
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
26 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Sanaz Hariri’s office at (408) 871-1800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A104189 · Current
Licensed to practise in California · since 2008 · expires 2028-04-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Forest Surgery Center LPAmbulatory Surgery Center · San Jose, CAOwner · accredited by JCAccreditation Renewed1 inspection, 1 with deficiencies · last 2012-09-18: Requirements Met
- Knowles Surgery Center, LLCAmbulatory Surgery Center · Los Gatos, CA12.5% owner since 2012 · accredited by AAAASFProbation3 inspections, 2 with deficiencies · last 2017-05-23: Requirements Met
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA1.79% owner since 2012 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA1.79% owner since 2012 · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$541,265
Medicare paid this office $541,265 for 624 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 237 | $118,385 | None |
| Short return visit (20+ min) | 413 | $107,265 | $84 |
| Aspiration and/or injection of fluid from large joint | 338 | $99,250 | $71 |
| Return visit (30+ min) | 376 | $66,343 | $111 |
| Replacement of knee joint, both sides of knee | 32 | $37,187 | $1,162 |
See all 20 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 237 | $118,385 | None |
| Short return visit (20+ min) | 413 | $107,265 | $84 |
| Aspiration and/or injection of fluid from large joint | 338 | $99,250 | $71 |
| Return visit (30+ min) | 376 | $66,343 | $111 |
| Replacement of knee joint, both sides of knee | 32 | $37,187 | $1,162 |
| New patient visit (45+ min) | 160 | $22,888 | $143 |
| Repair of shoulder rotator cuff using an endoscope | 17 | $16,774 | $987 |
| Long return visit (40+ min) | 77 | $12,810 | $151 |
| Incision of knee joint with removal of cartilage of front and back of knee | 32 | $11,519 | $360 |
| Repair of dislocating kneecap with realignment | 32 | $11,171 | $349 |
| New patient visit (30+ min) | 60 | $5,758 | $96 |
| Removal of both knee cartilages using an endoscope | 11 | $5,461 | $496 |
| Diagnostic exam of knee using an endoscope | 14 | $2,759 | $197 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 16 | $2,381 | $149 |
| Removal of extensive shoulder joint tissue using an endoscope | 14 | $1,593 | $114 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 271 | $1,508 | None |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 17 | $894 | $53 |
| Aspiration and/or injection of fluid from large joint | 32 | $647 | $20 |
| Injection, methylprednisolone acetate, 1 mg | 26 | $294 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 222 | $6 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 48 | More than 98% of doctors who do this |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 44 | More than 83% of doctors who do this |
Who their Medicare patients are
624 Original Medicare patients in 2024. Average age 76 · Women 67% · Also on Medicaid 3% · Health risk score 0.88. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 68% · Coronary heart disease 28% · Diabetes 23% · Cancer 16% · Atrial fibrillation 14% · Depression 14% · Chronic kidney disease 12% · Heart failure 10% · COPD 10% · Stroke 6% · Dementia 5%.
The office billed $2,879,373, Medicare allowed $702,774 and paid $541,265; for 10,378 services of 39 kinds; $126,706 of it was for drugs given in the office and $414,559 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 624 | 10,378 | 76 | 0.88 | $2,879,373 | $541,265 |
| 2023 | 647 | 8,027 | 76 | 0.85 | $3,063,991 | $579,319 |
| 2022 | 588 | 7,702 | 76 | 0.87 | $2,757,426 | $531,687 |
| 2021 | 556 | 7,654 | 76 | 0.85 | $2,695,077 | $493,919 |
| 2020 | 515 | 7,450 | 75 | 0.88 | $2,358,738 | $480,430 |
| 2019 | 551 | 7,278 | 75 | 0.88 | $1,785,025 | $522,042 |
| 2018 | 479 | 6,588 | 75 | 0.90 | $1,682,587 | $434,776 |
| 2017 | 447 | 6,643 | 75 | 0.88 | $1,491,192 | $427,514 |
| 2016 | 427 | 5,632 | 74 | 0.93 | $1,414,034 | $389,683 |
| 2015 | 384 | 4,183 | 74 | 0.92 | $1,225,366 | $329,342 |
| 2014 | 349 | 3,323 | 74 | 0.83 | $1,201,144 | $311,106 |
| 2013 | 226 | 2,198 | 74 | 0.82 | $753,315 | $188,866 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 262 | $131,618 | None |
| Short return visit (20+ min) | 431 | $109,452 | $84 |
| Aspiration and/or injection of fluid from large joint | 376 | $105,505 | $73 |
| Return visit (30+ min) | 416 | $76,799 | $114 |
| Replacement of knee joint, both sides of knee | 35 | $42,934 | $1,193 |
| New patient visit (45+ min) | 166 | $23,593 | $141 |
| Incision of knee joint with removal of cartilage of front and back of knee | 35 | $13,283 | $369 |
| Repair of dislocating kneecap with realignment | 35 | $12,896 | $358 |
| Repair of shoulder rotator cuff using an endoscope | 12 | $12,178 | $1,015 |
| New patient visit (30+ min) | 82 | $8,268 | $101 |
| Removal of both knee cartilages using an endoscope | 15 | $8,222 | $548 |
| Long return visit (40+ min) | 49 | $7,993 | $160 |
| Diagnostic exam of knee using an endoscope | 21 | $4,207 | $200 |
| New patient visit (60+ min) | 15 | $2,923 | $195 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 12 | $1,857 | $155 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 302 | $1,782 | None |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 20 | $1,083 | $52 |
| Aspiration and/or injection of fluid from large joint | 35 | $746 | $21 |
| Injection, methylprednisolone acetate, 80 mg | 41 | $559 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 330 | $9 | None |
2022: 18 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 259 | $138,598 | None |
| Aspiration and/or injection of fluid from large joint | 369 | $99,639 | $69 |
| Short return visit (20+ min) | 375 | $77,031 | $82 |
| Return visit (30+ min) | 313 | $54,844 | $114 |
| Replacement of knee joint, both sides of knee | 39 | $48,714 | $1,188 |
| Short return visit | 144 | $19,656 | $51 |
| New patient visit (45+ min) | 124 | $18,128 | $146 |
| Incision of knee joint with removal of cartilage of front and back of knee | 39 | $14,954 | $365 |
| Repair of dislocating kneecap with realignment | 39 | $14,540 | $355 |
| Long return visit (40+ min) | 47 | $8,435 | $169 |
| New patient visit (30+ min) | 95 | $7,554 | $80 |
| New patient visit (60+ min) | 15 | $3,070 | $205 |
| Diagnostic exam of knee using an endoscope | 11 | $2,175 | $198 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 36 | $1,936 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 295 | $1,808 | None |
| Aspiration and/or injection of fluid from large joint | 39 | $847 | $21 |
| Injection, methylprednisolone acetate, 80 mg | 53 | $677 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 332 | $10 | None |
2021: 25 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 220 | $114,705 | None |
| Aspiration and/or injection of fluid from large joint | 357 | $93,867 | $70 |
| Short return visit (20+ min) | 341 | $58,518 | $81 |
| Replacement of knee joint, both sides of knee | 31 | $38,870 | $1,215 |
| Short return visit | 234 | $38,781 | $55 |
| Return visit (30+ min) | 195 | $29,726 | $115 |
| Repair of shoulder rotator cuff using an endoscope | 15 | $15,379 | $1,025 |
| New patient visit (30+ min) | 146 | $15,190 | $104 |
| Incision of knee joint with removal of cartilage of front and back of knee | 31 | $11,882 | $371 |
| Repair of dislocating kneecap with realignment | 31 | $11,562 | $361 |
| New patient visit (45+ min) | 81 | $10,895 | $135 |
| Removal of both knee cartilages using an endoscope | 19 | $10,462 | $551 |
| Long return visit (40+ min) | 34 | $6,185 | $159 |
| Diagnostic exam of knee using an endoscope | 25 | $5,012 | $200 |
| Mri scan of leg joint without contrast | 45 | $2,670 | $59 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 15 | $2,390 | $159 |
| Mri scan of arm joint without contrast | 33 | $2,137 | $61 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 279 | $1,863 | None |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 34 | $1,801 | $51 |
| Removal of extensive shoulder joint tissue using an endoscope | 15 | $1,727 | $115 |
| X-ray of knee, 4 or more views | 114 | $1,131 | $10 |
| Injection, methylprednisolone acetate, 80 mg | 95 | $1,129 | None |
| Aspiration and/or injection of fluid from large joint | 30 | $658 | $21 |
| X-ray of shoulder, minimum of 2 views | 53 | $404 | $8 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 335 | $10 | None |
2020: 23 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 209 | $113,028 | None |
| Aspiration and/or injection of fluid from large joint | 345 | $88,766 | $67 |
| Short return visit (20+ min) | 381 | $78,779 | $69 |
| Replacement of knee joint, both sides of knee | 38 | $49,278 | $1,264 |
| Return visit (30+ min) | 304 | $45,135 | $97 |
| New patient visit (45+ min) | 166 | $24,693 | $149 |
| Repair of shoulder rotator cuff using an endoscope | 14 | $14,371 | $1,026 |
| Incision of knee joint with removal of cartilage of front and back of knee | 38 | $14,340 | $368 |
| Repair of dislocating kneecap with realignment | 38 | $13,964 | $358 |
| Mri scan of arm joint without contrast | 52 | $3,436 | $62 |
| Mri scan of leg joint without contrast | 50 | $3,090 | $61 |
| Removal of extensive shoulder joint tissue using an endoscope | 14 | $2,569 | $183 |
| Long return visit (40+ min) | 18 | $2,507 | $139 |
| New patient visit (60+ min) | 11 | $2,122 | $193 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 13 | $2,104 | $162 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 268 | $2,087 | None |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 36 | $1,860 | $52 |
| X-ray of knee, 4 or more views | 174 | $1,812 | $10 |
| Injection, methylprednisolone acetate, 80 mg | 96 | $1,214 | None |
| Aspiration and/or injection of fluid from large joint | 38 | $834 | $21 |
| X-ray of shoulder, minimum of 2 views | 53 | $463 | $9 |
| X-ray of knee, 1-2 views | 21 | $158 | $8 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 319 | $10 | None |
2019: 24 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 193 | $176,868 | None |
| Aspiration and/or injection of fluid from large joint | 357 | $76,503 | $61 |
| Return visit (30+ min) | 315 | $52,882 | $99 |
| Short return visit (20+ min) | 356 | $49,325 | $66 |
| Replacement of knee joint, both sides of knee | 31 | $38,483 | $1,241 |
| New patient visit (45+ min) | 205 | $29,791 | $145 |
| Repair of shoulder rotator cuff using an endoscope | 13 | $12,210 | $939 |
| Incision of knee joint with removal of cartilage of front and back of knee | 32 | $11,432 | $357 |
| Repair of dislocating kneecap with realignment | 32 | $11,140 | $348 |
| Short return visit | 120 | $10,052 | $42 |
| Repair of knee joint with drilling and or scraping of joint using an endoscope | 14 | $8,576 | $613 |
| Diagnostic exam of knee using an endoscope | 24 | $4,592 | $191 |
| Mri scan of leg joint without contrast | 70 | $4,518 | $61 |
| Removal of both knee cartilages using an endoscope | 12 | $2,830 | $236 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 284 | $2,328 | None |
| Removal of extensive shoulder joint tissue using an endoscope | 13 | $2,248 | $173 |
| X-ray of knee, 4 or more views | 181 | $1,902 | $10 |
| Mri scan of arm joint without contrast | 27 | $1,648 | $61 |
| Injection, methylprednisolone acetate, 80 mg | 79 | $1,130 | None |
| Aspiration and/or injection of fluid from large joint | 34 | $752 | $22 |
| X-ray of shoulder, minimum of 2 views | 57 | $489 | $9 |
| X-ray of knee, 1-2 views | 38 | $266 | $7 |
| Injection, methylprednisolone acetate, 40 mg | 14 | $63 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 331 | $14 | None |
2018: 29 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 163 | $84,558 | None |
| Aspiration and/or injection of fluid from large joint | 301 | $63,456 | $59 |
| Short return visit (20+ min) | 343 | $56,208 | $64 |
| Replacement of knee joint, both sides of knee | 34 | $41,826 | $1,195 |
| Repair of shoulder rotator cuff using an endoscope | 30 | $28,452 | $948 |
| Return visit (30+ min) | 200 | $26,474 | $94 |
| New patient visit (45+ min) | 171 | $23,874 | $140 |
| Repair of knee joint with drilling and or scraping of joint using an endoscope | 24 | $14,419 | $601 |
| Incision of knee joint with removal of cartilage of front and back of knee | 34 | $12,051 | $344 |
| Repair of dislocating kneecap with realignment | 34 | $11,729 | $335 |
| Short return visit | 153 | $7,774 | $40 |
| Diagnostic exam of knee using an endoscope | 34 | $6,369 | $187 |
| Mri scan of leg joint without contrast | 69 | $4,536 | $59 |
| Removal of both knee cartilages using an endoscope | 20 | $4,270 | $213 |
| Mri scan of arm joint without contrast | 66 | $4,120 | $60 |
| Removal of extensive shoulder joint tissue using an endoscope | 30 | $4,062 | $135 |
| Removal of knee cartilage using an endoscope | 12 | $2,882 | $240 |
| X-ray of knee, 4 or more views | 201 | $2,629 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 233 | $2,363 | None |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 15 | $2,290 | $153 |
| New patient visit (60+ min) | 12 | $2,223 | $185 |
| Long return visit (40+ min) | 11 | $1,451 | $132 |
| Partial removal of shoulder joint lining using an endoscope | 20 | $1,140 | $57 |
| Injection, methylprednisolone acetate, 80 mg | 81 | $1,109 | None |
| Aspiration and/or injection of fluid from large joint | 35 | $732 | $20 |
| X-ray of shoulder, minimum of 2 views | 68 | $588 | $8 |
| X-ray of knee, 1-2 views | 40 | $330 | $7 |
| Measurement of range of motion in arm, leg or each spine section | 13 | $293 | $20 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 284 | $9 | None |
2017: 29 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 132 | $67,054 | None |
| Aspiration and/or injection of fluid from large joint | 275 | $53,027 | $60 |
| Replacement of knee joint, both sides of knee | 36 | $45,291 | $1,224 |
| Short return visit (20+ min) | 261 | $42,141 | $68 |
| Return visit (30+ min) | 259 | $38,120 | $96 |
| New patient visit (45+ min) | 178 | $25,907 | $146 |
| Repair of knee joint with drilling and or scraping of joint using an endoscope | 34 | $19,596 | $576 |
| Injection of drug or substance under skin or into muscle | 229 | $18,870 | $26 |
| Repair of shoulder rotator cuff using an endoscope | 13 | $13,576 | $970 |
| Incision of knee joint with removal of cartilage of front and back of knee | 38 | $13,392 | $343 |
| Repair of dislocating kneecap with realignment | 37 | $12,944 | $341 |
| Removal of joint lining from multiple knee joint compartments using an endoscope | 29 | $10,994 | $379 |
| Diagnostic exam of knee using an endoscope | 48 | $9,188 | $191 |
| Short return visit | 123 | $6,294 | $42 |
| Mri scan of leg joint without contrast | 91 | $5,956 | $61 |
| Removal of both knee cartilages using an endoscope | 34 | $5,850 | $172 |
| Mri scan of arm joint without contrast | 51 | $3,511 | $62 |
| Removal of extensive shoulder joint tissue using an endoscope | 14 | $2,660 | $177 |
| X-ray of knee, 4 or more views | 191 | $2,441 | $10 |
| Removal of knee cartilage using an endoscope | 11 | $2,213 | $201 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 13 | $2,180 | $156 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 212 | $1,882 | None |
| Aspiration and/or injection of fluid from large joint | 44 | $913 | $21 |
| Injection, methylprednisolone acetate, 80 mg | 69 | $878 | None |
| Partial removal of shoulder joint lining using an endoscope | 13 | $789 | $56 |
| X-ray of shoulder, minimum of 2 views | 61 | $568 | $9 |
| Measurement of range of motion in arm, leg or each spine section | 21 | $411 | $18 |
| X-ray of knee, 1-2 views | 39 | $360 | $7 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 267 | $9 | None |
2016: 31 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 129 | $71,827 | None |
| Aspiration and/or injection of fluid from large joint | 277 | $52,579 | $60 |
| Return visit (30+ min) | 291 | $46,033 | $95 |
| Replacement of knee joint, both sides of knee | 37 | $45,369 | $1,194 |
| Short return visit (20+ min) | 200 | $29,842 | $67 |
| New patient visit (45+ min) | 198 | $28,954 | $146 |
| Repair of shoulder rotator cuff using an endoscope | 17 | $16,656 | $925 |
| Incision of knee joint with removal of cartilage of front and back of knee | 36 | $12,657 | $342 |
| Repair of dislocating kneecap with realignment | 36 | $12,310 | $333 |
| Repair of knee joint with drilling and or scraping of joint using an endoscope | 17 | $9,773 | $575 |
| Short return visit | 128 | $6,374 | $40 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 13 | $6,315 | None |
| Mri scan of leg joint without contrast | 80 | $5,180 | $60 |
| Diagnostic exam of knee using an endoscope | 17 | $3,193 | $188 |
| New patient visit (60+ min) | 16 | $2,984 | $186 |
| Mri scan of arm joint without contrast | 48 | $2,891 | $60 |
| Long return visit (40+ min) | 20 | $2,786 | $133 |
| X-ray of knee, 4 or more views | 192 | $2,651 | $10 |
| Removal of both knee cartilages using an endoscope | 14 | $2,629 | $188 |
| Removal of extensive shoulder joint tissue using an endoscope | 16 | $2,585 | $162 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 11 | $1,826 | $152 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 190 | $1,667 | None |
| Mri scan of arm without contrast | 21 | $1,257 | $60 |
| Injection, methylprednisolone acetate, 80 mg | 105 | $1,013 | None |
| Partial removal of shoulder joint lining using an endoscope | 13 | $735 | $57 |
| Aspiration and/or injection of fluid from large joint | 35 | $724 | $20 |
| X-ray of shoulder, minimum of 2 views | 76 | $687 | $8 |
| Injection of drug or substance under skin or into muscle | 11 | $482 | $24 |
| X-ray of knee, 1-2 views | 43 | $358 | $7 |
| X-ray of hip, 2-3 views | 11 | $110 | $10 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 269 | $9 | None |
2015: 32 services
| Return visit (30+ min) | 278 | $50,145 | $99 |
| Replacement of knee joint, both sides of knee | 28 | $35,423 | $1,221 |
| Aspiration and/or injection of fluid from large joint | 207 | $34,464 | $61 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 56 | $30,682 | None |
| New patient visit (45+ min) | 166 | $24,963 | $150 |
| Repair of shoulder rotator cuff using an endoscope | 25 | $24,199 | $968 |
| Short return visit (20+ min) | 121 | $15,230 | $68 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 18 | $14,686 | None |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 24 | $10,450 | None |
| Incision of knee joint with removal of cartilage of front and back of knee | 28 | $10,159 | $350 |
| Repair of dislocating kneecap with realignment | 28 | $9,892 | $341 |
| Repair of knee joint with drilling and or scraping of joint using an endoscope | 17 | $8,497 | $500 |
| Removal of joint lining from multiple knee joint compartments using an endoscope | 19 | $8,359 | $440 |
| New patient visit (60+ min) | 32 | $5,959 | $186 |
| Diagnostic exam of knee using an endoscope | 25 | $4,894 | $196 |
| Long return visit (40+ min) | 32 | $4,336 | $131 |
| Removal of extensive shoulder joint tissue using an endoscope | 26 | $3,998 | $154 |
| Short return visit | 59 | $3,307 | $42 |
| Mri scan of arm without contrast | 45 | $3,024 | $60 |
| Removal of both knee cartilages using an endoscope | 18 | $2,923 | $162 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 17 | $2,643 | $155 |
| X-ray of knee, 4 or more views | 161 | $2,446 | $10 |
| Mri scan of leg without contrast | 35 | $2,297 | $60 |
| Mri scan of leg joint without contrast | 22 | $1,447 | $60 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 136 | $1,259 | None |
| Partial removal of shoulder joint lining using an endoscope | 18 | $1,045 | $58 |
| Mri scan of arm joint without contrast | 12 | $744 | $62 |
| X-ray of shoulder, minimum of 2 views | 68 | $641 | $9 |
| Aspiration and/or injection of fluid from large joint | 28 | $600 | $21 |
| Injection, methylprednisolone acetate, 80 mg | 74 | $487 | None |
| X-ray of knee, 1-2 views | 42 | $381 | $8 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 194 | $6 | None |
2014: 29 services
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 74 | $38,681 | None |
| Replacement of knee joint, both sides of knee | 29 | $35,580 | $1,186 |
| Return visit (30+ min) | 234 | $34,890 | $96 |
| Aspiration and/or injection of fluid from large joint | 166 | $29,799 | $61 |
| Repair of shoulder rotator cuff using an endoscope | 23 | $22,370 | $973 |
| New patient visit (45+ min) | 133 | $20,157 | $152 |
| Repair of knee joint with drilling and or scraping of joint using an endoscope | 24 | $13,820 | $576 |
| Short return visit (20+ min) | 99 | $11,029 | $68 |
| New patient visit (60+ min) | 56 | $10,446 | $187 |
| Incision of knee joint with removal of cartilage of front and back of knee | 28 | $10,089 | $348 |
| Long return visit (40+ min) | 68 | $10,050 | $131 |
| Repair of dislocating kneecap with realignment | 28 | $9,831 | $339 |
| Removal of joint lining from multiple knee joint compartments using an endoscope | 24 | $8,330 | $347 |
| Diagnostic exam of knee using an endoscope | 41 | $8,009 | $195 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 14 | $7,117 | None |
| Short return visit | 70 | $5,067 | $40 |
| Removal of both knee cartilages using an endoscope | 28 | $4,724 | $169 |
| Removal of extensive shoulder joint tissue using an endoscope | 23 | $4,103 | $178 |
| Mri scan of leg without contrast | 62 | $4,000 | $60 |
| Mri scan of arm without contrast | 59 | $3,697 | $61 |
| X-ray of knee, 4 or more views | 133 | $1,962 | $10 |
| Partial removal of shoulder joint lining using an endoscope | 21 | $1,278 | $61 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 101 | $797 | None |
| Aspiration and/or injection of fluid from large joint | 23 | $475 | $21 |
| X-ray of shoulder, minimum of 2 views | 41 | $427 | $9 |
| X-ray of knee, 1-2 views | 37 | $371 | $8 |
| Injection, methylprednisolone acetate, 80 mg | 52 | $287 | None |
| X-ray of ribs of one side of body, minimum of 2 views | 13 | $143 | $10 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 98 | $3 | None |
2013: 26 services
| Repair of shoulder rotator cuff using an endoscope | 23 | $21,777 | $947 |
| Aspiration and/or injection of fluid from large joint | 116 | $21,711 | $59 |
| Replacement of knee joint, both sides of knee | 15 | $20,579 | $1,372 |
| Return visit (30+ min) | 127 | $19,286 | $95 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 28 | $12,550 | None |
| New patient visit (45+ min) | 83 | $12,379 | $149 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 20 | $8,774 | None |
| Short return visit | 45 | $6,844 | $42 |
| Incision of knee joint with removal of cartilage of front and back of knee | 15 | $5,207 | $347 |
| Repair of dislocating kneecap with realignment | 15 | $5,074 | $338 |
| Short return visit (20+ min) | 60 | $5,003 | $65 |
| New patient visit (60+ min) | 25 | $4,544 | $182 |
| Diagnostic exam of knee using an endoscope | 22 | $4,195 | $191 |
| Removal of both knee cartilages using an endoscope | 15 | $3,571 | $238 |
| Removal of extensive shoulder joint tissue using an endoscope | 21 | $3,365 | $160 |
| Mri scan of leg without contrast | 50 | $2,994 | $56 |
| Long return visit (40+ min) | 21 | $2,884 | $131 |
| Mri scan of arm without contrast | 39 | $2,375 | $58 |
| New patient visit (30+ min) | 21 | $2,086 | $99 |
| Partial removal of shoulder joint lining using an endoscope | 15 | $1,319 | $88 |
| X-ray of knee, 4 or more views | 82 | $1,194 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 66 | $480 | None |
| X-ray of shoulder, minimum of 2 views | 33 | $306 | $8 |
| X-ray of knee, 1-2 views | 15 | $156 | $8 |
| Injection, methylprednisolone acetate, 80 mg | 29 | $148 | None |
| X-ray of ribs of one side of body, minimum of 2 views | 11 | $127 | $10 |
Drugs they prescribed that Part D paid
$3,275
Pharmacies billed $3,275 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 28% of their Part D prescriptions (127 of 451) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
445 generic and fewer than 11 brand-name prescriptions · $3,275 in drug cost · 210 antibiotic prescriptions to 90 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone | 60 | $519 | $9 |
| Celecoxib | 27 | $464 | $17 |
| Amoxicillin | 170 | $397 | $2 |
| Cyclobenzaprine | 13 | $197 | $15 |
| Tramadol | 35 | $154 | $4 |
See all 10 drugs
| Oxycodone | 60 | $519 | $9 |
| Celecoxib | 27 | $464 | $17 |
| Amoxicillin | 170 | $397 | $2 |
| Cyclobenzaprine | 13 | $197 | $15 |
| Tramadol | 35 | $154 | $4 |
| Ondansetron Odt | 13 | $116 | $9 |
| Hydromorphone | 11 | $116 | $11 |
| Meloxicam | 28 | $103 | $4 |
| Hydrocodone-Acetaminophen | 17 | $77 | $5 |
| Clindamycin | 12 | $49 | $4 |
Year by year
| 2024 | 451 | 155 | 28% (127) | None | $3,275 |
| 2023 | 485 | 159 | 28% (137) | None | $3,735 |
| 2022 | 444 | 145 | 34% (151) | 4% | $4,751 |
| 2021 | 490 | 161 | 32% (158) | None | $5,858 |
| 2020 | 393 | 131 | 39% (152) | 4% | $5,857 |
| 2019 | 377 | 140 | 41% (156) | 3% | $3,583 |
| 2018 | 372 | 143 | 42% (157) | 6% | $4,215 |
| 2017 | 434 | 147 | 52% (225) | 15% | $6,248 |
| 2016 | 471 | 131 | 48% (227) | 17% | $11,223 |
| 2015 | 425 | 129 | 50% (213) | 20% | $14,012 |
| 2014 | 404 | 119 | 55% (223) | 28% | $14,828 |
| 2013 | 252 | 83 | 55% (138) | 24% | $8,498 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Celecoxib | 26 | $976 | $38 |
| Oxycodone | 55 | $643 | $12 |
| Ondansetron Odt | 34 | $391 | $12 |
| Pregabalin | 15 | $271 | $18 |
| Amoxicillin | 147 | $247 | $2 |
| Meloxicam | 58 | $241 | $4 |
| Tramadol | 58 | $213 | $4 |
| Hydrocodone-Acetaminophen | 13 | $45 | $3 |
| Ibuprofen | 12 | $18 | $2 |
2022: 8 drugs
| Oxycodone | 53 | $695 | $13 |
| Tramadol | 60 | $259 | $4 |
| Meloxicam | 69 | $233 | $3 |
| Ondansetron Odt | 16 | $159 | $10 |
| Amoxicillin | 125 | $146 | $1 |
| Hydrocodone-Acetaminophen | 24 | $139 | $6 |
| Hydromorphone | 11 | $51 | $5 |
| Clindamycin | 14 | $23 | $2 |
2021: 11 drugs
| Celecoxib | 20 | $754 | $38 |
| Oxycodone | 48 | $490 | $10 |
| Hydromorphone | 26 | $275 | $11 |
| Meloxicam | 77 | $237 | $3 |
| Tramadol | 56 | $189 | $3 |
| Amoxicillin | 127 | $157 | $1 |
| Cyclobenzaprine | 16 | $156 | $10 |
| Ondansetron Odt | 14 | $146 | $10 |
| Cephalexin | 13 | $144 | $11 |
| Hydrocodone-Acetaminophen | 25 | $132 | $5 |
| Clindamycin | 21 | $36 | $2 |
2020: 9 drugs
| Oxycodone | 57 | $560 | $10 |
| Diclofenac | 16 | $358 | $22 |
| Tramadol | 59 | $194 | $3 |
| Meloxicam | 51 | $186 | $4 |
| Hydromorphone | 19 | $171 | $9 |
| Amoxicillin | 91 | $137 | $2 |
| Ondansetron Odt | 13 | $124 | $10 |
| Hydrocodone-Acetaminophen | 15 | $77 | $5 |
| Clindamycin | 13 | $19 | $1 |
2019: 8 drugs
| Diclofenac | 15 | $513 | $34 |
| Oxycodone | 47 | $513 | $11 |
| Meloxicam | 52 | $331 | $6 |
| Tramadol | 65 | $301 | $5 |
| Amoxicillin | 85 | $114 | $1 |
| Hydromorphone | 13 | $110 | $8 |
| Hydrocodone-Acetaminophen | 25 | $100 | $4 |
| Clindamycin | 14 | $34 | $2 |
2018: 8 drugs
| Oxycodone-Acetaminophen | 23 | $530 | $23 |
| Meloxicam | 61 | $434 | $7 |
| Hydromorphone | 23 | $360 | $16 |
| Tramadol | 43 | $261 | $6 |
| Oxycodone | 20 | $215 | $11 |
| Hydrocodone-Acetaminophen | 33 | $195 | $6 |
| Amoxicillin | 75 | $114 | $2 |
| Cephalexin | 13 | $67 | $5 |
2017: 9 drugs
| Oxycontin | 22 | $931 | $42 |
| Hydromorphone | 47 | $536 | $11 |
| Oxycodone-Acetaminophen | 25 | $371 | $15 |
| Hydrocodone-Acetaminophen | 51 | $308 | $6 |
| Tramadol | 59 | $304 | $5 |
| Meloxicam | 55 | $283 | $5 |
| Oxycodone | 13 | $101 | $8 |
| Amoxicillin | 49 | $89 | $2 |
| Ondansetron Odt | 11 | $63 | $6 |
2016: 11 drugs
| Voltaren | 14 | $1,800 | $129 |
| Oxycontin | 26 | $1,086 | $42 |
| Hydromorphone | 47 | $635 | $14 |
| Hydrocodone-Acetaminophen | 41 | $525 | $13 |
| Tramadol | 72 | $445 | $6 |
| Oxycodone-Acetaminophen | 18 | $431 | $24 |
| Ibuprofen | 32 | $253 | $8 |
| Oxycodone | 18 | $234 | $13 |
| Meloxicam | 25 | $209 | $8 |
| Amoxicillin | 42 | $110 | $3 |
| Clindamycin | 21 | $35 | $2 |
2015: 12 drugs
| Enoxaparin | 17 | $2,793 | $164 |
| Celecoxib | 13 | $1,873 | $144 |
| Oxycontin | 23 | $1,048 | $46 |
| Oxycodone-Acetaminophen | 35 | $931 | $27 |
| Voltaren | 14 | $659 | $47 |
| Hydromorphone | 43 | $452 | $11 |
| Hydrocodone-Acetaminophen | 39 | $362 | $9 |
| Ibuprofen | 32 | $316 | $10 |
| Tramadol | 55 | $279 | $5 |
| Cyclobenzaprine | 12 | $218 | $18 |
| Meloxicam | 31 | $211 | $7 |
| Amoxicillin | 29 | $73 | $3 |
2014: 10 drugs
| Enoxaparin | 13 | $2,563 | $197 |
| Oxycontin | 35 | $1,213 | $35 |
| Hydromorphone | 72 | $706 | $10 |
| Oxycodone-Acetaminophen | 26 | $678 | $26 |
| Voltaren | 16 | $677 | $42 |
| Hydrocodone-Acetaminophen | 50 | $449 | $9 |
| Ibuprofen | 40 | $293 | $7 |
| Meloxicam | 32 | $198 | $6 |
| Tramadol | 32 | $186 | $6 |
| Amoxicillin | 15 | $68 | $5 |
2013: 7 drugs
| Enoxaparin | 13 | $3,483 | $268 |
| Voltaren | 22 | $855 | $39 |
| Hydrocodone-Acetaminophen | 53 | $686 | $13 |
| Oxycontin | 16 | $523 | $33 |
| Oxycodone-Acetaminophen | 19 | $158 | $8 |
| Tramadol | 24 | $152 | $6 |
| Ibuprofen | 11 | $113 | $10 |
Money from drug and device companies
$60 in 2025
| 2025 | 2 | 3 | None | $60 |
| 2023 | 3 | 3 | None | $46 |
| 2022 | 3 | 3 | None | $55 |
| 2021 | 3 | 3 | None | $163 |
| 2020 | 1 | 1 | None | $22 |
| 2019 | 7 | 9 | None | $535 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Avanos Medical | On-Q Pump and Accessories | $42 | 2 payments
|
| Vertex Pharmaceuticals | Journavx | $18 | 1 payment
|
See all 3 published payments
| Avanos Medical | Meals · 2025-12-17 | On-Q Pump and Accessories | $22 |
| Avanos Medical | Meals · 2025-08-27 | On-Q Pump and Accessories | $20 |
| Vertex Pharmaceuticals | Meals · 2025-06-26 | Journavx | $18 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $46
| SPR Therapeutics | Sprint Pns System | $17 | 1 payment
|
| Evolution Surgical | None | $15 | 1 payment
|
| DePuy Synthes Sales | Orthovisc | $13 | 1 payment
|
2022: $55
| Kowa Pharmaceuticals America | Seglentis | $22 | 1 payment
|
| Trevena | Olinvyk | $19 | 1 payment
|
| Ethicon US | Stratafix | $14 | 1 payment
|
2021: $163
| Heron Therapeutics | Zynrelef | $122 | 1 payment
|
| AcelRx Pharmaceuticals | Dsuvia | $21 | 1 payment
|
| Ethicon US | Stratafix | $20 | 1 payment
|
2020: $22
| Ermi | None | $22 | 1 payment
|
2019: $535
| NuVasive | None | $143 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $125 | 1 payment
|
| Smith+Nephew | Regeneten | $121 | 1 payment
|
| Medtronic USA | Aquamantys | $99 | 3 payments
|
| AcelRx Pharmaceuticals | Dsuvia | $17 | 1 payment
|
| Stryker | Mako | $16 | 1 payment
|
| Kci USA | Vac Veraflo | $15 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 92.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological EvaluationAs Medicare defines this measure | 100% | 29 |
| Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of FootwearAs Medicare defines this measure | 100% | 29 |
| Falls: Plan of CareAs Medicare defines this measure | 100% | 22 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 4,191 |
| Patient-Centered Surgical Risk Assessment and CommunicationAs Medicare defines this measure | 100% | 163 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 1,343 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1134255888
- Licence
- CA A104189California A104189: Current · expires 2028-04-30
- Trained
- Stanford University School of Medicine, 2003
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 1169 Trinity Dr, Menlo Park, CA, 94025
- NPI first listed
- 2007-02-26
- NPI last updated
- 2023-02-26
- NPI record certified
- 2023-02-26
This is when the NPI record was last certified, not a medical board exam.